Michael Cannon
Director/Board Member chez MOLECULIN BIOTECH, INC.
Fortune : - $ au 31/03/2024
Profil
Michael D.
Cannon is currently a Director at Osel, Inc., Eureka Therapeutics, Inc., Moleculin Biotech, Inc., and Executive Director at Biosentinel, Inc. He previously served as Director, Chief Science Officer & Executive VP at SICOR, Inc. from 1997 to 2004.
He also held director positions at Metabasis Therapeutics, Inc., Athenex, Inc., Waterstone Pharmaceuticals, Inc., and Antiva Biosciences, Inc. Additionally, he was a Strategic Partner at Trevi Management LP.
Cannon received his undergraduate degree from Fordham University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
MOLECULIN BIOTECH, INC.
-.--% | 26/12/2023 | 0 ( -.--% ) | - $ | 31/03/2024 |
Postes actifs de Michael Cannon
| Sociétés | Poste | Début |
|---|---|---|
| MOLECULIN BIOTECH, INC. | Director/Board Member | 01/07/2015 |
Eureka Therapeutics, Inc.
 Eureka Therapeutics, Inc. BiotechnologyHealth Technology Eureka Therapeutics, Inc. develops therapeutic monoclonal antibodies for cancer indication and treatment. It focuses on the discovery of fully-human antibody drugs for the treatment of cancer and utilizing its antibody drug discovery and engineering technologies, and advancing therapies for targeting previously inaccessible cancer antigens. The company was founded by Cheng Liu in 2006 and is headquartered in Emeryville, CA. | Director/Board Member | - |
Osel, Inc.
 Osel, Inc. Pharmaceuticals: MajorHealth Technology Osel, Inc. develops and commercializes live bio therapeutic products that prevent abnormal conditions resulting from a disruption of the human micro biome. It offers Lactin-V and CBM588 products. The company was founded by Peter P. Lee in 2003 and is headquartered in Mountain View, CA. | Director/Board Member | - |
Biosentinel, Inc.
 Biosentinel, Inc. BiotechnologyHealth Technology Biosentinel, Inc. develops tests for the detection of the botulinum neurotoxins. The private company is based in Madison. | Director/Board Member | 01/07/2010 |
Anciens postes connus de Michael Cannon
| Sociétés | Poste | Fin |
|---|---|---|
SICOR, Inc.
 SICOR, Inc. Pharmaceuticals: MajorHealth Technology Part of Teva Pharmaceutical Industries Ltd., SICOR, Inc. is a private company that manufactures pharmaceuticals. The company is based in San Diego, CA. The company was founded by Harry E. Gruber, Jack W. Reich, Paul K. Laikind, Robert L. Engler. SICOR was acquired by Teva Pharmaceutical Industries Ltd. on January 22, 2004 for $3,297.10 million. | Chief Tech/Sci/R&D Officer | 01/01/2004 |
| ATHENEXPAR | Director/Board Member | - |
Antiva Biosciences, Inc.
 Antiva Biosciences, Inc. BiotechnologyHealth Technology Antiva Biosciences, Inc. is a biopharmaceutical company developing novel, topical therapeutics for the treatment of diseases caused by HPV infection. The company was founded by Karl Y. Hostetler in 2012 and is headquartered in South San Francisco, CA. | Director/Board Member | - |
Metabasis Therapeutics, Inc.
 Metabasis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Metabasis Therapeutics, Inc. engages in discovery, development and commercialization of novel drugs for metabolic diseases using the proprietary technology and the knowledge of processes and pathways within the liver that are useful for liver-selective drug targeting and treatment of metabolic diseases. Metabasis was incorporated in April 1997 and is headquartered in La Jolla, CA. | Director/Board Member | - |
Waterstone Pharmaceuticals, Inc.
 Waterstone Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Waterstone Pharmaceuticals, Inc. engages in the provision of discovery, development, and commercialization of innovative drugs for the treatment of liver and gastrointestinal diseases. The company was founded by Faming Zhang in 2008 and is headquartered in Carmel, IN. | Director/Board Member | - |
Formation de Michael Cannon
| Fordham University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 10 |
|---|---|
SICOR, Inc.
SICOR, Inc. Pharmaceuticals: MajorHealth Technology Part of Teva Pharmaceutical Industries Ltd., SICOR, Inc. is a private company that manufactures pharmaceuticals. The company is based in San Diego, CA. The company was founded by Harry E. Gruber, Jack W. Reich, Paul K. Laikind, Robert L. Engler. SICOR was acquired by Teva Pharmaceutical Industries Ltd. on January 22, 2004 for $3,297.10 million. | Health Technology |
Metabasis Therapeutics, Inc.
Metabasis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Metabasis Therapeutics, Inc. engages in discovery, development and commercialization of novel drugs for metabolic diseases using the proprietary technology and the knowledge of processes and pathways within the liver that are useful for liver-selective drug targeting and treatment of metabolic diseases. Metabasis was incorporated in April 1997 and is headquartered in La Jolla, CA. | Health Technology |
Athenex, Inc.
 Athenex, Inc. Pharmaceuticals: MajorHealth Technology Athenex, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel therapies for the treatment of cancer. It operates through the Oncology Innovation Platform and Commercial Platform segments. The Oncology Innovation Platform segment focuses on the research and development of proprietary drugs. The Commercial Platform segment covers the sale and market of specialty drugs and market development of proprietary drugs. The company was founded by Lyn M. Dyster and David G. Hangauer in November 2003 and is headquartered in Buffalo, NY. | Health Technology |
Osel, Inc.
Osel, Inc. Pharmaceuticals: MajorHealth Technology Osel, Inc. develops and commercializes live bio therapeutic products that prevent abnormal conditions resulting from a disruption of the human micro biome. It offers Lactin-V and CBM588 products. The company was founded by Peter P. Lee in 2003 and is headquartered in Mountain View, CA. | Health Technology |
Eureka Therapeutics, Inc.
Eureka Therapeutics, Inc. BiotechnologyHealth Technology Eureka Therapeutics, Inc. develops therapeutic monoclonal antibodies for cancer indication and treatment. It focuses on the discovery of fully-human antibody drugs for the treatment of cancer and utilizing its antibody drug discovery and engineering technologies, and advancing therapies for targeting previously inaccessible cancer antigens. The company was founded by Cheng Liu in 2006 and is headquartered in Emeryville, CA. | Health Technology |
Waterstone Pharmaceuticals, Inc.
Waterstone Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Waterstone Pharmaceuticals, Inc. engages in the provision of discovery, development, and commercialization of innovative drugs for the treatment of liver and gastrointestinal diseases. The company was founded by Faming Zhang in 2008 and is headquartered in Carmel, IN. | Health Technology |
Antiva Biosciences, Inc.
Antiva Biosciences, Inc. BiotechnologyHealth Technology Antiva Biosciences, Inc. is a biopharmaceutical company developing novel, topical therapeutics for the treatment of diseases caused by HPV infection. The company was founded by Karl Y. Hostetler in 2012 and is headquartered in South San Francisco, CA. | Health Technology |
Trevi Management LP
 Trevi Management LP Investment ManagersFinance Trevi Management LP (Trevi Health Capital) is a private equity firm founded in 2005 by David Robbins and Andrew Fink. The firm is headquartered in New York with an additional office in London. | Finance |
| Moleculin Biotech, Inc. | |
Biosentinel, Inc.
Biosentinel, Inc. BiotechnologyHealth Technology Biosentinel, Inc. develops tests for the detection of the botulinum neurotoxins. The private company is based in Madison. | Health Technology |
